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INTRODUCTION
Pyoderma gangrenosum (PG) is an uncommon,
ulcerative cutaneous condition of uncertain
aetiology.1 It is associated with systemic
diseases in at least 50% of patients who are
affected.2 The diagnosis is made by excluding
other causes of similar-appearing cutaneous
ulcerations, including infection, malignancy,
vasculitis, collagen vascular diseases, diabetes
and trauma. In a process termed pathergy, new
ulcerations may occur after trauma or injury to
the skin in 30% of patients who already have
pyoderma gangrenosum.2
The classic ulcerative form of PG usually
observed on the legs, and a superficial variant
(atypical PG) tends to occur on the hands.
Patients with PG may have involvement of
other organ systems that manifests as sterile
neutrophilic infiltrates.  Culture-negative
pulmonary infiltrates are the most common
extracutaneous manifestation.2 Other organs
systems that may be involved include the heart,
the central nervous system, the gastrointestinal
(GI) tract, the eyes,the liver, the spleen, the
bones, the  lymph nodes  and the breast.
Although breast cancer would be the most
likely differential clinical diagnosis in any
patient with breast ulceration, other rare causes
should be considered. We report the case of a
young lady who presented with bilateral breast
ulcerations due to PG.
CASE REPORT
A 26-year-old lady presented with painful
ulcers on both breasts  of 3 months duration.
The first manifestation of ulcers first became
apparent following consumption of  oral
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medication prescribed by a local practitioner
for fever. The ulcer started as a small boil with
yellow discharge and then increased in size at
a rapid pace. Right breast was affected first
followed by left. The ulcer healed after a
fortnight to some extent. Subsequently,  the
ulcers recurred on both breasts  for which she
was treated with topical as well as systemic
medications by a local practitioner. The present
episode was the third recurrence. She had no
history of recent gastrointestinal upset, arthritis
or  other systemic symptoms. The patient had
not  previously  undergone  any  surgical
intervention nor a  biopsy from the ulcer site.
However,  she had received 4 units blood
transfusion for severe anaemia before reporting
to us.
Clinical examination revealed two ulcers,
located in the upper medial quadrant of  both
breasts,   measuring approximately 7 × 10 cm
(right breast) and 3 × 5 cm (left breast) in size.
The necrotic ulcers had violaceous undermined
border which were rapidly advancing. The
ulcers were very tender. Nipples were not
involved (Figure1). Oral examination showed
erosion in both retromolar pillars. Abdominal
examination was unremarkable. Laboratory
evaluation revealed haemoglobin 9.7 g/dL with
a normal mean corpuscular volume  (90.4 fL);
elevated total leucocyte count (40,800 / mm3);
the platelet count was 2.25 lakh/ mm3. In the
peripheral blood smear erythrocytes were
normocytic  and normochromic, neutrophils
were markedly increased and platelets were
adequate in number. No abnormal cells or
haemoparasites were seen. The erythrocyte
sedimentation rate (ESR) was elevated (26 mm
at the end of the first hour). Screening for auto
antibodies was negative. The culture and
sensitivity testing of the ulcer swab showed the
growth of Enterococcus faecalis. Urine culture
showed the growth of Klebsiella oxytoca.
Serum  biochemistry  was  normal.
Ultrasonography and mammography of both
breasts were normal.
Punch biopsy taken early in the disease and
from the advancing, erythematous border
showed  an infiltrate of chronic inflammatory
cells confined to the dermis (Figure 2). Features
suggestive of vasculitis were evident at the edge
of the ulcer, with a perivascular lymphocytic
infiltrate and fibrinoid necrosis of the dermal
vessel wall. Occasionally, extravasation of red
blood cells and areas of thrombosis was also
seen. Ulceration of the epidermis secondary to
dermal inflammation was present (Figure 2).
The patient was treated with oral prednisolone
50 mg daily and clofazimine 400 mg daily along
with topical corticosteroids (0.1% betametha-
sone cream) and topical tacrolimus 0.03% for
the first 4 weeks; systemic steroids were tapered
off and stopped. Symptomatic treatment was
administered for fever and anaemia. With this
treatment, the patient’s condition significantly
improved (Figures 3 and 4). After 6 weeks of
treatment, the ESR was 18mm at the end of
the first hour and the TLC became normal
(9000/mm3). Peripheral blood smear showed
decrease in neutrophil counts while other
findings remained as before, after 6 weeks of
treatment. She has been counselled to come for
regular follow-up visits  and  is still continuing
oral clofazimine along with topical immuno-
modulators.
Figure 1: Clinical photograph showing necrotic ulcers with
violaceous undermined borders  which were rapidly
advancing in the upper medial quadrant both breasts
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DISCUSSION
The incidence of PG is uncertain, but it is
estimated to be 3-10 patients per million
population per year.1 PF can occur can at any
age but is seen most commonly between 20 and
50 years of age;1
The aetiology of PG is unknown and the
pathogenesis is poorly understood. Although
the disease is idiopathic in 25%-50%  of
patients, an underlying immunologic abnor-
mality may exist as suggested by its frequent
association with systemic diseases like infla-
mmatory bowel disease (IBD), pulmonary,
cardiac, autoimmune disorders; and  neo-
plasia.1-3
Occurrence of the phenomenon of pathergy,
(i.e., the development of new lesions  or
aggravation of existing ones following trivial
trauma) frequently observed in PG would
suggest altered, exaggerated, and uncontrolled
inflammatory  responses  to  non-specific
stimuli.1
The term leukaemoid reaction describes an
elevated white blood cell count, or leucocyto-
sis, that is a physiological response to stress or
infection. Leukaemoid reactions are generally
benign and constitute a response to a significant
disease state.  Haemorrhage, drugs, infections,
asplenia and diabetic ketoacidosis are the
common causes of leukemoid reaction.
Immune status dysregulation  particularly
neutrophil  dysfunction  (i.e.,  defects  in
chemotaxis or hyperreactivity) in  individuals
with PG  has been suggested. Evidence of
abnormal neutrophil trafficking and metabolic
oscillations have also been described in PG.
These two factors would have resulted in the
development of leukaemoid reaction.
Figure 2: Photomicrograph showing lymphocytic
infiltrate within the dermis suggestive of vasculitis at
the edge of the ulcer, with a perivascular lymphocytic
infiltrate and fibrinoid necrosis of the dermal vessel wall
(Haematoxylin and eosin, × 1000)
Figure 3: Clincal photograph of right breast obtained
after 6 weeks of treatment with oral prednisolone, topical
tacrolimus and clofazimine
Figure 4: Clincal photograph obtained after 6 weeks
showing healed lesions in the left breast
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Diseases commonly associated with PG include
inflammatory bowel disease, ulcerative colitis,
Crohn’s disease. Haematologic disorders com-
monly associated with PG include leukaemia
or preleukaemic states (predominantly myelo-
cytic) and monoclonal gammopathies, prima-
rily of immunoglobulin A variety.4-6
Reported therapies for PG have often focussed
on treatment of the underlying condition.
Therefore, most information available relates
to systemic therapies, probably because many
PG lesions mimic the activity of the underlying
disease.7
First-line therapy includes immuno-suppres-
sants, such as corticosteroids (prednisolone/
methylprednisolone) and cyclosporin.8 Other
therapeutic  options  include  immuno-
modulators, biologicals and antileprosy drugs.
When an underlying disease is absent, as in our
patient PG can respond variably to standard
therapy. Further, PG can even recur after
definitive surgery for the underlying disease,
(e.g., colectomy).9
A case of PG of the sinus mammarum has been
documented in a patient with ulcerative colitis.9
In this case the cutaneous ulcer was resistant
to conventional systemic medical therapy
although the treatment resulted in improvement
in  the systemic  disease. Basing  on   the
histopathologic finding of vasculitis at the edge
of the lesions antithrombotic topical injections
were used as an adjunct to standard treatment.9
This case report suggested that perilesional
injections of calcic heparin were successful in
inducing remission.9
A retrospective analysis (n=20) showed that
topical steroids have little role in healing.3
Conversely, other authors have demonstrated
improvement of the lesions with intralesional
steroids.14
Surgery has to be used with caution since it
can  trigger PG . Any surgical procedure has to
be done as an adjunct to immunosuppression
only in patients with stable disease or partial
remission. Autologous split-skin grafts have
been  used  with  variable  outcome.10  A
significant disadvantage of split-skin grafts is
the necessity to create a new wound at the donor
site. Therefore, surgical intervention is not
recommended in standard practice.
In comparison with the previous cases of PG
with pathergy complicating coronary artery
bypass grafting (CABG),11-12 our patient’s case
seemed to be unusually severe, as evidenced
by the leukaemoid reaction. Two cases of
postoperative  PG  that  presented  with
leukaemoid reaction, have been reported.13
Till date 43 cases of PG of the breast have been
reported.1 In 30 of the cases PG lesions were
secondary to trauma to the breast tissue, such
as surgical intervention, reconstruction of the
breast, biopsy, and intramuscular injection.1 It
is likely that, the pathergy phenomenon may
be the reason for PG lesions occuring after
breast trauma.
Our patient had a rare presentation of PG of
the breast with leukaemoid reaction, in which
presently, there are  no signs of underlying
malignancy.  This  case  highlights  the
importance of considering PG as one of the
differential diagnoses of breast ulcers. Careful
specialist clinical assessment could establish
an early diagnosis and formulate an effective
management plan.  Our knowledge about
pathogenesis and individual risk factors for the
development of PG is still rather limited. This
hampers the efforts for prevention. However,
the appearance of new ulcers can be prevented
in patients known to have the disorder by
avoiding excessive trauma to the skin.
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